Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **fatty acid beta‐oxidation pathway** is a central mitochondrial process by which **fatty acids are broken down to generate energy**, primarily in the form of ATP. Medium‐chain fatty acids (MCFAs), such as octanoic and decanoic acids, are rapidly oxidized via this route. The process involves several key steps: 1. **Activation:** MCFAs are activated to their CoA derivatives by specific acyl-CoA synthetases. 2. **Transport:** Unlike long‐chain fatty acids that require carnitine shuttling into mitochondria, MCFAs can enter mitochondria more readily. 3. **Beta-Oxidation Cycle:** Inside mitochondria, a series of enzymatic reactions sequentially shortens the acyl chain by two carbons per cycle, producing acetyl-CoA for entry into the citric acid cycle and generating NADH/FADH₂ for oxidative phosphorylation[1][3]. 4. In humans and other mammals, these steps involve enzymes such as *medium-chain acyl-CoA dehydrogenase* (MCAD), enoyl-CoA hydratase, hydroxyacyl-CoA dehydrogenase, and ketoacyl-CoA thiolase[1][2]. This rapid oxidation is particularly important during fasting or ketogenic diets when glucose is scarce; it supports ketone body production for brain energy supply[4]. Defects in any step—especially MCAD deficiency—can lead to serious metabolic disorders. **Note on Target Validity:** "Energy metabolism via rapid oxidation of medium-chain fatty acids" describes a biological *process*, not a single molecular target like an enzyme or receptor. Therefore, - It is not considered a canonical therapeutic target. - The entry should be flagged as incorrect if strict molecular targeting information is required. References supporting these statements include detailed reviews on mitochondrial beta‐oxidation pathways and their role in health/disease[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid beta-oxidation pathway (medium-chain specificity).